The scheme for producers in Hainan and Yunnan provinces, the main...
Category:
Non-Life
Latest
Global healthcare benefit cost increases projected to largely continue into 2024, WTW survey finds
“The high cost of new medical technologies is a key reason for the...
MoRTH aims to halve road accidents and casualties by 2030: Gadkari
Nitin Gadkari,Union Minister,Ministry of Road Transport and...
Passenger vehicle sales decline 49.59% in June over coronavirus, lockdown
According to the latest data by the Society of Indian Automobile Manufacturers (SIAM), two-wheeler sales were also down 38.56 per cent at 10,13,431 units as compared to 16,49,475 units in the same month last year.
India has now less stunted children but more obese adults
More Indian adults became obese between 2012-16, the report said.
The number of adults (18 years and older) who are obese grew from 25.2 million in 2012 to 34.3 million in 2016, growing from 3.1 per cent to 3.9 per cent.
Govt approves Rs 107 cr for fire-fighting facilities at Haldia Dock
The modern fire-fighting facility will enable Haldia Dock Complex in safe handling of the movement of petro-chemical products, it said.
The existing fire-fighting facility does not support the handling the LPG and other petroleum products as per the guideline of Oil Industry Safety Directorate (OISD) of the Ministry of Petroleum and Natural Gas, it added.
The shipping ministry said it has prioritised safety and security of cargo operation on all major ports and the move is towards compliance of global standards for fire safety.
Network Hospitals have to provide cashless facility to policyholders:IRDAI
,it is clarified that the policyholders are entitled to cashless facility at all such network providers (hospital) with whom the Insurance company/TPA has entered into an agreement in accordance to the norms of SLA.
In the event of denial of cashless facility at any such enlisted network providers (hospitals) the aggrieved policyholders may send a complaint to the concerned insurance company.
Asian waters account for most shipping losses,global numbers hit record low:AGCS
According to the report, the South China, Indochina, Indonesia and Philippines maritime region remains the top loss location with 12 vessels in 2019 and 228 vessels over the past decade – one in four of all losses. The Japan, Korea and North China region saw 2 vessels lost in 2019 and is the third largest loss location overall with 104 since 2010. High levels of trade, busy shipping lanes, older fleets, typhoon exposure, and safety issues on some domestic ferry routes are contributing factors. However, in 2019, losses declined for the second successive year, mirroring a global trend.
Record spike of 28,701 COVID-19 cases takes India’s tally to 8,78,254
Death toll climbed to 23,174 with 500 people succumbing to the infection, according to the Union Health Ministry data.
Around 63.01 per cent of patients have recovered so far”
Glenmark cuts price of COVID-19 drug favipiravir version to $1 per tablet
Glenmark last month received Indian regulatory approval to make and sell anti-flu drug favipiravir, which is manufactured under the brand name Avigan by a unit of Japan’s Fujifilm Holdings Corp.
Glenmark had priced FabiFlu at 103 rupees per tablet earlier, making it one of the cheapest COVID-19 treatment available in the country.
“Glenmark’s price reduction aims to make FabiFlu further accessible for COVID-19 patients across the country,” the company said in a statement
Markel appoints Head of Renewable Energy,first ever based in Asia
Commenting on the new appointment,Rohan Davies, divisional managing director of energy, Market, said,“Tom’s solid track record and wealth of international experience in renewable energy are invaluable as we continue our ambitious plans for growth in this important sector.“Markel has a strong reputation of delivering leading risk-transfer products and service in the energy space. With Tom strategically based in the rapidly growing Asian market, his appointment as Markel’s new global head is a reflection of our commitment to renewable energy in our global portfolio.”
WHO warns that coronavirus crisis may get ‘worse and worse and worse
“Let me be blunt, too many countries are headed in the wrong direction, the virus remains public enemy number one,” WHO Director General Tedros Adhanom Ghebreyesus told a virtual briefing from the U.N. agency’s headquarters in Geneva.
Biocon secures approval to use drug on coronavirus patients
“The randomised control trial indicated that all the patients treated with Itolizumab responded positively and recovered,” said Kiran Mazumdar-Shaw, the firm’s executive chairperson.
The control group which did not receive Itolizumab unfortunately suffered deaths, she said, adding that the “first-in-class” drug will save lives and help reduce the mortality rate in India.